These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6710068)

  • 21. [Treatment of hyperthyroidism with radioiodine: effects of administered dose on complications and thyroid function].
    Pineda P; Michelsen H; Rivera M; Lillo R; Massardo T; Araya V; Sierralta P; Oviedo S; Liberman C
    Rev Med Chil; 2000 May; 128(5):499-507. PubMed ID: 11008353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radio-iodine (NaI131) therapy in hyperthyroidism.
    Chakrabarti B
    J Indian Med Assoc; 2001 Nov; 99(11):642-5. PubMed ID: 12022208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
    Vijayakumar V; Ali S; Nishino T; Nusynowitz M
    Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of the administered radioiodine doses for the treatment of hyperthyroidism in Belgium.
    Tondeur M; Glinoer D; Sand A; Verelst J; Ham H
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):206-9. PubMed ID: 16886961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of feline hyperthyroidism with radioactive iodine-131].
    van Dijl IC; Hof AJ
    Tijdschr Diergeneeskd; 2008 Jan; 133(2):54-62. PubMed ID: 18246946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Basedow-Graves' hyperthyroidism: retrospective analysis after 30 years].
    Pineda G; Arancibia P; Mejía G
    Rev Med Chil; 1998 Aug; 126(8):953-62. PubMed ID: 9830747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodine treatment of hyperthyroidism at the Tikur Anbessa Hospital.
    Demena S; Abdulkadir J; Jorge Y
    Ethiop Med J; 2001 Jan; 39(1):39-46. PubMed ID: 11338466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
    Véliz J; Pineda G; Arancibia P; Wohllk N
    Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term comparative cancer mortality after use of radio-iodine in the treatment of hyperthyroidism, a fully reported multicenter study.
    Singer RB
    J Insur Med; 2001; 33(2):138-42. PubMed ID: 11510511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
    Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
    J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 131I therapy of toxic and non-toxic goiters.
    Beckers C
    Q J Nucl Med; 1999 Dec; 43(4):291-6. PubMed ID: 10731779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [131I: the definitive treatment of choice in diffuse toxic goiter].
    García-Luna PP; Rodríguez JR; García Solís D; Astorga Jiménez R
    Med Clin (Barc); 1985 Feb; 84(7):291-2. PubMed ID: 3982148
    [No Abstract]   [Full Text] [Related]  

  • 37. [Whole body counting of 131I administered patients with hyperthyroidism, and estimations of absorbed doses of 131I to various organs (author's transl)].
    Saegusa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Jun; 34(6):404-15. PubMed ID: 4216878
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our experience with the 131-I treatment of thyrotoxicosis].
    Raĭnova R; Ivanov I
    Vutr Boles; 1975; 14(3):32-9. PubMed ID: 1226718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Suppressibility of the thyroid gland during drug therapy of hyperthyroidism. Significance of goiter size and thyroglobulin antibodies].
    Hackenberg K; Schneider KR; Reinwein D
    Dtsch Med Wochenschr; 1972 Aug; 97(34):1264-6. PubMed ID: 5048321
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioactive iodine for hyperthyroidism in children and adolescents: referral rate and response to treatment.
    McCormack S; Mitchell DM; Woo M; Levitsky LL; Ross DS; Misra M
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):884-91. PubMed ID: 19250263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.